Medigene, IRICoR and Université de Montréal Sign Collaboration and Exclusive Licensing Option on Novel Cancer Antigens

NEXT STORY
The veterinary rapid tests market is projected to grow at a CAGR of 8.3%
PREV STORY
Onxeo Enters Clinical Research Agreement with Gustave Roussy to Conduct Clinical Trial of AsiDNA™ for Treatment of Relapsed Ovarian Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chi-Med Highlights Oral Presentations at 2019 ESMO Asia Annual Meeting

author_avatar
NASDAQ Market News

iTeos annonce ses résultats financiers pour le deuxième trimestre 2021 et présente l’actualité de ses activités

author_avatar
NASDAQ Market News

iCAD announces positive study results comparing use of company’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer

NASHUA, N.H., July 19, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider ...

author_avatar
NASDAQ Market News